Join
Live feed
·
INSIDERFilingvia Quantisnow
Apellis Pharmaceuticals Inc. logo

Chief People Officer Boucher Kelley was granted 45,219 shares and returned 173,023 shares to the company, closing all direct ownership in the company (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APLS (Apellis Pharmaceuticals Inc.) and more on Quantisnow.